Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer.

MedStar author(s):
Citation: Methodist DeBakey cardiovascular journal. 19(1):15-19, 2023.PMID: 36742441Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: *Heart Failure | *Heart-Assist Devices | *Neoplasms | Feasibility Studies | Heart Failure/th [Therapy] | Humans | Retrospective StudiesYear: 2023ISSN:
  • 1947-6108
Name of journal: Methodist DeBakey cardiovascular journalAbstract: The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two patients at our institution. Copyright: © 2023 The Author(s).All authors: Butt N, Sheikh FHFiscal year: FY2023Digital Object Identifier: ORCID: Date added to catalog: 2023-04-11
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article Available

The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two patients at our institution. Copyright: © 2023 The Author(s).

English

Powered by Koha